Microvast vs Vicor
Vicor reported revenue of $453 million in fiscal 2025, about the same as Microvast's $428 million in fiscal 2025. Microvast's revenue grew 12.6% in its latest year, and Vicor's grew 26.1%. Microvast had an operating margin of 1.6%, against 18.1% at Vicor. Free cash flow was $56 million at Microvast and $119 million at Vicor.
Side by side
| Microvast | Vicor | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $428M | $453M |
| Revenue growth | 12.6% | 26.1% |
| Revenue growth a year, last 5 years | 31.8% | 8.8% |
| Gross margin | 28.6% | 57.3% |
| Operating margin | 1.6% | 18.1% |
| Net margin | −6.8% | 26.2% |
| Free cash flow | $56M | $119M |
| Free cash flow margin | 13.1% | 26.3% |
| Return on capital | 1.3% | — |
| Net debt to EBITDA | 0.0x | — |
| Dividends and buybacks | $0M | $35M |
| Change in diluted share count | 2.0% | 0.6% |
| Last close | $0.25 | $141.52 |
| P/E at the last close | — | 37.0× |
| Insider trades, last 12 months | sold $178,434 | sold $396.8 million |
| Piotroski F-score | 5 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
MicrovastVicor
Operating margin
Percent of revenue
MicrovastVicor
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MicrovastVicor